Pulike Biological Engineering, Inc. (603566.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.26B
Enterprise Value4.18B
P/E Ratio23.8
PEG Ratio3.17
Price/Sales Ratio3.44
Price/Book Ratio1.38
Enterprise/Revenue3.42
Enterprise/EBITDA15.93

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.14
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.06

Income Statement

Revenue1.09B
Revenue/Share2.99
Gross Profit652.53M
EBITDA329.88M
Net Income184.99M
Diluted EPS0.54

Balance Sheet

Total Cash734.77M
Total Cash/Share2.15
Total Debt67.91M
Total Debt/Equity0.03
Current Ratio3.46
Book Value Per Share7.81

Price History

52-Week Change-29.75
52-Week High14.65
52-Week Low9.56
Moving Average 50 Days10.39
Moving Average 200 Days11.94

Statistics

Average Volume3.18M
Shares Outstanding341.92M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.6
Trailing Annual Dividend Yield5.84
Payout Ratio0.47
Last Split Factor2:1
Last Split DateMay 31, 2016
AD